SCHEMBL30740333

SCHEMBL30740333

CCc1cccc(-c2nnn(C)c2COC2CCCCO2)n1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 1/20 0.37
▸ TGFBR1 P36897 7/20 0.36
▸ TGFBR2 P37173 1/20 0.36
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ ABCC3 O15438 2/20 0.32
▸ ABCC4 O15439 2/20 0.32
▸ SLCO1B3 Q9NPD5 2/20 0.32
▸ SLCO1B1 Q9Y6L6 2/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ EP300 Q09472 1/20 0.31
▸ CREBBP Q92793 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ ABCB11 O95342 1/20 0.31
▸ LPAR1 Q92633 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22576664 1.00 KDM4C (0.37) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL30460098 0.84 TGFBR1 (0.36) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL30740368 0.83 TGFBR1 (0.44) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL29067956 0.83 SLCO1B1 (0.33) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL29922208 0.83 SLCO1B1 (0.33) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL27157558 0.83 SLCO1B1 (0.33) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL24982985 0.82 SLCO1B1 (0.39) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL29411759 0.81 SLCO1B1 (0.38) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL19715601 0.81 SLCO1B1 (0.36) KDM4CTGFBR1TGFBR2NPC1RAB9A
SCHEMBL19715757 0.81 SLCO1B1 (0.38) KDM4CTGFBR1TGFBR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024022314-A1 TRIAZOLE COMPOUNDS AND USE THEREOF AS LPAR1 ANTAGONIST 武汉人福创新药物研发中心有限公司 2024-02-01 — — WO disclosed
Send feedback